Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01720810 · ClinicalTrials.gov registry record
Pacific Northwest Udall Center (PANUC) Clinical Core
A clinical trial of Parkinson Disease and Cognitive Impairment, sponsored by University of Washington.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT01720810: Recruiting study of Parkinson Disease and Cognitive Impairment, sponsored by University of Washington.
NCT01720810 is a study of Parkinson Disease and Cognitive Impairment that is actively recruiting participants, run by University of Washington. The registered enrollment target is 2,000 participants, below the 5,320-participant average among 297 other Parkinson Disease trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01720810, a study of Parkinson Disease and Cognitive Impairment, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates cognitive impairment in subjects with Parkinson disease (PD) and similar neurological disorder through obtaining longitudinal clinical and neuropsychological data. The long term goal is to have a well-characterized subject population to contribute to our understanding of the natural history, diagnosis and ultimate treatment of cognitive impairment in patients with PD and similar disorders.
Conditions Studied
Study Locations (1)
Washington
- VA Puget Sound Health Care System - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2010-03 |
| Est. Completion | 2025-10-31 |
What NCT01720810 shows while recruiting
NCT01720810 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 5,320-participant average among 297 other Parkinson Disease trials with a reported enrollment target (62% lower).
The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01720810 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01720810 about?
NCT01720810 is a clinical study titled "Pacific Northwest Udall Center (PANUC) Clinical Core". This study evaluates cognitive impairment in subjects with Parkinson disease (PD) and similar neurological disorder through obtaining longitudinal clinical and neuropsychological data. The long term goal is to have a well-characterized subject population to contribute to our understanding of the nat...
What is the current status of trial NCT01720810?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2010-03. Estimated completion is 2025-10-31.
What conditions does trial NCT01720810 study?
This clinical trial studies the following conditions: Parkinson Disease, Cognitive Impairment.
Who is sponsoring clinical trial NCT01720810?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01720810 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01720810's enrollment target sits among peer trials
2,000 10th of 297 higher than 287 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia